Table 2 Preventive drugs used in studied patients
From: Real-world evidence of galcanezumab for migraine treatment in Japan: a retrospective analysis
EM (n = 25) | CM (n = 27) | All (n = 52) | |
|---|---|---|---|
Types of migraine preventives | |||
Lomerizine | 15 (60.0) | 15 (55.6) | 30 (57.7) |
Propranolol | 6 (24.0) | 5 (18.5) | 11 (21.2) |
Valproate | 18 (72.0) | 18 (66.7) | 36 (69.2) |
Amitriptyline | 9 (36.0) | 10 (37.0) | 19 (36.5) |
Topiramate | 3 (12.0) | 7 (25.9) | 10 (19.2) |
Number of previous migraine preventives | |||
1 | 9 (36.0) | 15 (55.6) | 24 (46.2) |
2 | 9 (36.0) | 4 (14.8) | 13 (25.0) |
3 | 4 (16.0) | 3 (11.1) | 7 (13.5) |
≥ 4 | 3 (12.0) | 5 (18.5) | 8 (15.4) |
Mean | 2.0 ± 1.2 | 2.0 ± 1.4 | 2.0 ± 1.3 |
Use of migraine preventives at the first dosage | |||
No | 9 (36.0) | 18 (66.7) | 27 (51.9) |
Yes | 16 (64.0) | 9 (33.3) | 25 (48.1) |
Discontinued | 3 (12.0) | 0 (0.0) | 3 (5.8) |
Continued | 13 (52.0) | 9 (33.3) | 22 (42.3) |